| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $84.3B | $84.0B | $82.0B | $80.2B | $76.1B | $17.7B | $17.1B | $16.5B |
| Cost of Revenue | $41.2B | $40.8B | $42.8B | $42.2B | $37.1B | $35.3B | $34.8B | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $2.1B | $2.0B | $2.0B | $2.0B | $1.9B | $1.8B | $1.9B | $1.9B |
| SG&A Expense | $22.7B | $23.3B | $21.1B | $20.2B | $21.0B | $20.0B | $19.1B | $18.9B |
| Operating Income | $20.5B | $18.5B | $18.1B | $17.8B | $18.0B | $3.5B | $-5.2B | $2.7B |
| Net Income | $16.0B | $14.9B | $14.7B | $14.7B | $14.3B | $2.8B | $-5.2B | $1.9B |
| EPS (Basic) | $6.67 | $6.18 | $6.07 | $6.00 | $5.69 | $5.13 | $1.45 | $3.75 |
| EPS (Diluted) | $6.51 | $6.02 | $5.90 | $5.81 | $5.50 | $1.07 | $-2.12 | $0.72 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $125.2B | $122.4B | $120.8B | $117.2B | $119.3B | $120.7B | $115.1B | $118.3B |
| Current Assets | $25.4B | $24.7B | $22.6B | $21.7B | $23.1B | $28.0B | $22.5B | $23.3B |
| Cash & Equivalents | — | — | — | — | — | — | $4.2B | $2.6B |
| Total Liabilities | $72.9B | $71.8B | $73.8B | $70.4B | $72.7B | $73.8B | $67.5B | $65.4B |
| Current Liabilities | $36.1B | $33.6B | $35.8B | $33.1B | $33.1B | $33.0B | $30.0B | $28.2B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17.8B | $19.8B | $16.8B | $16.7B | $18.4B | $17.4B | $15.2B | $14.9B |
| Investing Cash Flow | $-3.8B | $-3.5B | $-3.5B | $-4.4B | $-2.8B | $3.0B | $-3.5B | $-3.5B |
| Capital Expenditures | $3.8B | $3.3B | $3.1B | $3.2B | $2.8B | $3.1B | $3.3B | $3.7B |
| Financing Cash Flow | $-14.0B | $-14.9B | $-12.1B | $-14.9B | $-21.5B | $-8.4B | $-10.0B | $-14.4B |